StreetInsider.com News Articles

Form SCHEDULE 13G/A Acadia Healthcare Compan Filed by: Khrom Investments Fund, LP

Fri, 14 Aug 2026 06:35:00 -0400

si-local-file:///var/storage/secattach/20260814/26924252.html

Form SCHEDULE 13G/A Acadia Healthcare Compan Filed by: Khrom Investments Fund, LP

Fri, 14 Aug 2026 06:35:00 -0400

si-local-file:///var/storage/secattach/20260814/26924252.html

Form SCHEDULE 13G/A Acadia Healthcare Compan Filed by: WELLINGTON MANAGEMENT GROUP LLP

Thu, 13 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260813/26921020.html

Form SCHEDULE 13G/A Acadia Healthcare Compan Filed by: WELLINGTON MANAGEMENT GROUP LLP

Thu, 13 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260813/26921020.html

Form SCHEDULE 13G/A Acadia Healthcare Compan Filed by: FMR LLC

Thu, 06 Aug 2026 10:15:00 -0400

si-local-file:///var/storage/secattach/20260806/26881003.html

Form SCHEDULE 13G/A Acadia Healthcare Compan Filed by: FMR LLC

Thu, 06 Aug 2026 10:15:00 -0400

si-local-file:///var/storage/secattach/20260806/26881003.html

Acadia Healthcare (ACHC) PT Raised to $39 at Guggenheim

Thu, 30 Jul 2026 07:29:10 -0400

(Updated - July 30, 2026 7:29 AM EDT)

Guggenheim analyst Jason Cassorla raised the price target on Acadia Healthcare (NASDAQ: ACHC) to $39.00 (from $38.00) while maintaining a Buy rating.

The analyst commented: "ACHC reported 2Q26 core EBITDA upside, with strong volumes and solid expense management as the company works through improving ramping bed occupancy. However, the stock fell ~16% (vs S&P 500 -1.5%) in reaction to the print, driven by a combination of heightened buyside expectations and incremental PLGL expenses pressuring what otherwise would have been >500 bps of annualized growth from OOP FL DPP. Despite these dynamics, we assume that

Acadia Healthcare (ACHC) PT Raised to $39 at Guggenheim

Thu, 30 Jul 2026 07:29:10 -0400

(Updated - July 30, 2026 7:29 AM EDT)

Guggenheim analyst Jason Cassorla raised the price target on Acadia Healthcare (NASDAQ: ACHC) to $39.00 (from $38.00) while maintaining a Buy rating.

Acadia Healthcare (ACHC) PT Raised to $32 at Barclays

Thu, 30 Jul 2026 04:57:07 -0400

Barclays analyst Andrew Mok raised the price target on Acadia Healthcare (NASDAQ: ACHC) to $32.00 (from $25.00) while maintaining a Equalweight rating.

Form 8-K Acadia Healthcare Compan For: Jul 28

Tue, 28 Jul 2026 16:57:00 -0400

si-local-file:///var/storage/secattach/20260728/26828143.html

Form 8-K Acadia Healthcare Compan For: Jul 28

Tue, 28 Jul 2026 16:57:00 -0400

si-local-file:///var/storage/secattach/20260728/26828143.html

Form 10-Q Acadia Healthcare Compan For: Jun 30

Tue, 28 Jul 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260728/26827652.html

Form 10-Q Acadia Healthcare Compan For: Jun 30

Tue, 28 Jul 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260728/26827652.html

Acadia Healthcare (ACHC) Tops Q2 EPS by 2c ; Offers Guidance

Tue, 28 Jul 2026 16:08:16 -0400

Acadia Healthcare (NASDAQ: ACHC) reported Q2 EPS of $0.38, $0.02 better than the analyst estimate of $0.36. Revenue for the quarter came in at $865.8 million versus the consensus estimate of $844.11 million.

GUIDANCE:

Acadia Healthcare sees FY2026 EPS of $1.45-$1.60, versus the consensus of $1.52. Acadia Healthcare sees FY2026 revenue of $3.4-3.45 billion, versus the consensus of $3.41 billion.

For earnings history and earnings-related data on Acadia Healthcare (ACHC) click here.

Acadia Healthcare (ACHC) Tops Q2 EPS by 2c ; Offers Guidance

Tue, 28 Jul 2026 16:08:16 -0400

GUIDANCE:

Acadia Healthcare sees FY2026 EPS of $1.45-$1.60, versus the consensus of $1.52. Acadia Healthcare sees FY2026 revenue of $3.4-3.45 billion, versus the consensus of $3.41 billion.

For earnings history and earnings-related data on Acadia Healthcare (ACHC) click here.

Acadia Healthcare Announces Second Quarter 2026 Results and Updates Full Year 2026 Financial and Cash Flow Guidance